Jason Baker, MD

submenu

Assistant Professor of Medicine

Education

Medical School: University of Wisconsin, Madison
Fellowship: UMN, Minneapolis
Bachelor's: University of Wisconsin, Madison
Master's: UMN, Minneapolis
Other Education: Oregon Health & Science University

Administrative Contact

General Information
E: IDIM
P: (612) 624-9996
F: (612) 625-4410

Mailing Address
Hennepin County Medical Center
Medicine Office
701 Park Avenue
Minneapolis, MN 55415

Bio Statement

Research and Clinical Focus

Dr. Jason Baker is an Assistant Professor of Medicine in the Division of Infectious Diseases at University of Minnesota, and staff physician at Hennepin County Medical Center (HCMC) in Minneapolis, Minnesota. His clinical practice consists of inpatient general infectious disease consultation and inpatient/outpatient HIV medicine. His research focus includes the pathogenesis of cardiovascular disease in HIV-infected patients, and evaluating prevention strategies in this population. He currently collaborates with Drs. Jim Neaton, Keith Henry, Daniel Duprez and Richard Grimm. Dr. Baker works with an NIH HIV trial network (INSIGHT), serving as a co-convener for their CVD Interest Group, on the protocol team for the START trial, and as a co-chair for a cardiovascular substudy of START. In addition to studies originating at HCMC, he also works with a multi-center HIV-cohort study funded by CDC (the SUN Study).

Training

Dr. Baker completed post-secondary education at the University of Wisconsin (BS 1996; MD 2001). He completed Internal Medicine training (2001-2004) at Oregon Health & Science University (OHSU) in Portland, Oregon. He then completed a clinical and research fellowship in Infectious Diseases and International Medicine at the University of Minnesota, where he also earned a Master's of Science in Clinical Research (2007).

Publications

  • Baker JV, Neuhaus J, Duprez D, Cooper DA, Hoy J, Kuller L, Lampe FC, Liappis A, Friis-Moller N, Otvos J, Paton NI, Tracy RP, Neaton JN for the INSIGHT SMART Study Group. Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapy. AIDS 2011
  • Baker JV, Henry WK, Patel P, Bush TJ, Conley LJ, Mack WJ, Overton ET, Budoff M, Hammer J, Carpenter CC, Hodis HN, Brooks JT for the SUN Study Investigators. Progression of Carotid Intima-Media Thickness in a Contemporary HIV Cohort. Clinical Infectious Diseases 2011.
  • Baker JV and Lundgren J. Cardiovascular Implications of Untreated HIV Infections. European Heart Journal 2011;32(8):945-51.
  • Baker JV and Henry K. If we can't get what we want, can we get what we need? -- optimizing use of antiretroviral therapy in the current era (editorial). Annals of Internal Medicine 2011;154:563-5
  • Baker JV, Neuhaus J, Duprez D, Kuller LH, Tracy RP, Belloso WH, De Wit S, Drummond F, Lane HC, Ledergerber B, Lundgren J, Nixon DE, Paton NI, and Neaton JD for the INSIGHT SMART Study Group. Changes in Inflammatory and Coagulation Biomarkers: A Randomized Comparison of Immediate Versus Deferred Antiretroviral Therapy in Patients with HIV Infection. Journal of AIDS 2011;56(1):36-43 (PMID 20930640)
  • Neuhaus J, Jacobs DR, Baker JV, Calmy A, Duprez D, La Rosa A, Kuller LH, Pett S, Ristola M, Ross MJ, Shlipak MG, Tracy R, and Neaton JD for the INSIGHT SMART, MESA and CARDIA Research Groups. Markers of inflammation, coagulation and renal function in adults with HIV infection and in two population based cohorts. Journal of Infectious Diseases 2010;201(12):1788-95 (PMID: 20446848; PMC 3005856)
  • Baker JV, Ayenew W, Quick H, Huppler Hullsiek K, Tracy R, Henry K, Duprez D, Neaton JD. High-density lipoprotein particles and markers of inflammation and thrombotic activity in patients with untreated HIV infection. Journal of Infectious Diseases 2010;201(2):285-292 (PMID: 19954384; PMC2798007)
  • Baker JV, Peng G, Rapkin J, Abrams D, Silverberg MJ, MacArthur RD, Cavert WP, Henry WK, Neaton JD for the Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). CD4+ cell count and risk of non-AIDS diseases following initial treatment for HIV infection. AIDS 2008;22(7):841-848. (PMID: 18427202)